Mustang Bio Inc expected to post a loss of 20 cents a share - Earnings Preview

Mustang Bio

11/08/2021 03:51

* Mustang Bio Inc  MBIO.OQ   MBIO.O  is expected to show a no
change in quarterly revenue when it reports results on August 11
(estimated). 
​* Refinitiv's mean analyst estimate for Mustang Bio Inc is for
a loss of 20 cents per share. For the same quarter last year,
the company reported a loss of 32 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Mustang Bio Inc
is $11​, about 74.5% above​ its last closing price of $2.80. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.19       -0.19      -0.19     Met     2.6
 Dec. 31 2020  -0.20       -0.21      -0.32     Missed  -54.2
 Sep. 30 2020  -0.25       -0.25      -0.23     Beat    8​
 Jun. 30 2020  -0.27       -0.27      -0.32     Missed  -20
 Mar.          -0.31​      -0.31      -0.28     Beat    8.7​
 31​ 2020​                                              
 Dec. 31 2019              -0.26      -0.42     Missed  -59.5​
 Sep. 30 2019  -0.26       -0.26      -0.25     Beat    5.1
 Jun. 30 2019  -0.25       -0.25      -0.29     Missed  -14.5
 This summary was machine generated August 11 at 02:51 GMT.  All
figures in US dollars unless otherwise stated